Vestibular Migraine: Clinical Trials

3 trials for Vestibular Migraine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Not yet recruiting 1, Recruiting 1

Follow Vestibular Migraine: new trials by email Literature Review of Vestibular Migraine trials Research Report on Vestibular Migraine

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Galcanezumab, Erenumab 70 mg, Eptinezumab - Migraine Associated Vertigo, Tinnitus
Phase 4Not yet recruitingStanford University1202026-07-012026-06-17
Acute Treatment of Vestibular Migraine by Rimegepant
First dose rimegepant, second dose placebo, First dose placebo, second dose rimegepant - Vestibular Migraine
Phase 4RecruitingWensheng Qu802025-12-012026-10-13
Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine
Propranolol, Venlafaxine - Vestibular Migraine
Phase 4CompletedHaseki Training and Research Hospital732014-01-012015-01-30

Narrower conditions

Migraine Disorders (2)  ·  Headache Disorders (1)  ·  Tinnitus (1)  ·  Vertigo (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Ear Diseases (2)  ·  Headache Disorders, Primary (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Headache Disorders (1)  ·  Hearing Disorders (1)  ·  Labyrinth Diseases (1)  ·  Sensation Disorders (1)  ·  Vestibular Diseases (1)

Interventions

Propranolol (2)  ·  Amitriptyline (1)  ·  Nortriptyline (1)  ·  Topiramate (1)  ·  Venlafaxine Hydrochloride (1)  ·  Verapamil (1)  ·  atogepant (1)  ·  candesartan (1)  ·  eptinezumab (1)  ·  erenumab (1)  ·  galcanezumab (1)

Sponsors

Haseki Training and Research Hospital (1)  ·  Stanford University (1)  ·  Wensheng Qu (1)

Countries

China (1)  ·  Turkey (Türkiye) (1)

Top investigators

Kristen K. Steenerson (1)  ·  Matthew Fitzgerald (1)